Prospective feasible study for the postoperative urinastatin in patients with resectable lung cancer accompanied with interstitial pneumonitis
Phase 1
- Conditions
- interstitial pneumonitis lung cancer
- Registration Number
- JPRN-UMIN000006491
- Lead Sponsor
- Keio University School of Medicine, division of General Thoracic Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
a)asbestosis b)Patients with interstitial pneumonitis caused by connective tissue disease c)chronic hypersensitivity pneumonitis d)sarcoidosis e)Patients who have the history of allergic reactions against urinastatin f)Patients who are pregnant or have possibility of pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ntil 1POM, we are going to judge clinically whether adverse outcomes happen, which is thought to be side-effects caused by postoperative ulinastatin therapy.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie urinastatin's protective effects in interstitial pneumonitis post-lung cancer surgery?
How does urinastatin compare to standard-of-care treatments for preventing postoperative complications in interstitial pneumonitis patients with lung cancer?
Which biomarkers correlate with urinastatin response in resectable lung cancer patients with interstitial pneumonitis?
What are the potential adverse events associated with postoperative urinastatin administration in interstitial pneumonitis patients with lung cancer?
Are there combination therapies involving urinastatin that enhance outcomes in resectable lung cancer with interstitial pneumonitis?